BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34257001)

  • 21. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
    Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypofractionated radiation in older women with breast cancer.
    Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Rocque GB
    Breast J; 2019 Nov; 25(6):1206-1213. PubMed ID: 31359556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
    Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
    Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.
    Diwanji TP; Molitoris JK; Chhabra AM; Snider JW; Bentzen SM; Tkaczuk KH; Rosenblatt PY; Kesmodel SB; Bellavance EC; Cohen RJ; Cheston SB; Nichols EM; Feigenberg SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):445-453. PubMed ID: 28639030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
    Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
    Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
    Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
    Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy for young women with early breast cancer: Current state of the art.
    Meattini I; Lambertini M; Desideri I; De Caluwé A; Kaidar-Person O; Livi L
    Crit Rev Oncol Hematol; 2019 May; 137():143-153. PubMed ID: 31014510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
    Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
    Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
    Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
    Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancer.
    Chan EK; Woods R; Virani S; Speers C; Wai ES; Nichol A; McBride ML; Tyldesley S
    Radiother Oncol; 2015 Jan; 114(1):73-8. PubMed ID: 25227961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan.
    Chuang WK; Cheng SH; Hung CF; Huang TT; Jen CW; Yen JH; Tsai YC
    J Formos Med Assoc; 2022 Aug; 121(8):1588-1595. PubMed ID: 35094914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy.
    McClelland S; Burney HN; Zellars RC; Ohri N; Rhome RM
    Clin Breast Cancer; 2020 Dec; 20(6):469-479. PubMed ID: 32693964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis.
    Sun Y; Saulsberry L; Liao C; Hedeker D; Huo D
    Adv Radiat Oncol; 2024 Jun; 9(6):101487. PubMed ID: 38725638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lag Time Between Evidence and Guidelines: Can Clinical Pathways Bridge the Gap?
    Rodríguez-Lopéz JL; Ling DC; Heron DE; Beriwal S
    J Oncol Pract; 2019 Mar; 15(3):e195-e201. PubMed ID: 30526227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.
    Reddy JP; Lei X; Huang SC; Nicklaus KM; Fingeret MC; Shaitelman SF; Hunt KK; Buchholz TA; Merchant F; Markey MK; Smith BD
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):894-902. PubMed ID: 28333010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.
    Gupta A; Khan AJ; Yegya-Raman N; Sayan M; Ahlawat S; Ohri N; Goyal S; Moore DF; Eladoumikdachi F; Toppmeyer D; Haffty BG
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):267-274. PubMed ID: 31175905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.